Discussion about this post

User's avatar
Art's avatar

I would be curious as to how you, or Dr. Prasad, would design a study with this drug to answer the questions you think need to be answered.

Expand full comment
medstudent's avatar

This is getting so common. It seems half of oncology drugs are really of questionable benefit. I think I saw a research paper on that somewhere

Expand full comment
1 more comment...

No posts